Multiple Myeloma: International Myeloma Foundation : • webcasts   : webcasts from medical meetings : Dr. Reece - ASH 2008 - The Impact of Cytogenetics on the Outcomes of Treatment with Lenalidomide Plus Dexamethasone in Relapsed or Refractory Multiple Myeloma

webcasts from medical meetings

back

Dr. Reece - ASH 2008 - The Impact of Cytogenetics on the Outcomes of Treatment with Lenalidomide Plus Dexamethasone in Relapsed or Refractory Multiple Myeloma

Donna E. Reece, MD
Princess Margaret Hospital
Toronto, Ontario
Canada
Member, IMF Board of Scientific Advisors

	12.28.08
Be the first to comment Name Email Address URL Remember personal info? Comments (You may use HTML tags for style)	print share \| related articles

Be the first to comment